Needham & Company LLC reaffirmed their buy rating on shares of ACADIA Pharmaceuticals (NASDAQ:ACAD – Free Report) in a research report released on Tuesday, Benzinga reports. They currently have a $32.00 target price on the biopharmaceutical company’s stock. Several other brokerages have also issued reports on ACAD. HC Wainwright reissued a buy rating and issued […]

Needham & Company LLC reaffirmed their buy rating on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) in a research report sent to investors on Tuesday, Benzinga reports. Needham & Company LLC currently has a $60.00 price target on the stock. IONS has been the topic of several other reports. JPMorgan Chase & Co. raised […]

Needham & Company LLC reiterated their buy rating on shares of Surmodics (NASDAQ:SRDX – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. The brokerage currently has a $47.00 target price on the stock. Separately, StockNews.com raised Surmodics from a hold rating to a buy rating in a research note […]

Needham & Company LLC reissued their buy rating on shares of Merus (NASDAQ:MRUS – Free Report) in a research note published on Thursday morning, Benzinga reports. Needham & Company LLC currently has a $66.00 price target on the biotechnology company’s stock. A number of other research firms have also recently issued reports on MRUS. Truist […]

Needham & Company LLC restated their buy rating on shares of Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) in a research report released on Tuesday, Benzinga reports. Needham & Company LLC currently has a $85.00 price objective on the stock. APLS has been the topic of a number of other research reports. Raymond James lifted their […]

Needham & Company LLC reissued their buy rating on shares of Inozyme Pharma (NASDAQ:INZY – Free Report) in a research note issued to investors on Tuesday, Benzinga reports. Needham & Company LLC currently has a $23.00 target price on the stock. INZY has been the subject of several other reports. HC Wainwright reiterated a buy […]

Silicon Motion Technology (NASDAQ:SIMO – Free Report) had its price target raised by Needham & Company LLC from $75.00 to $85.00 in a research note released on Wednesday, Benzinga reports. They currently have a buy rating on the semiconductor producer’s stock. Other research analysts also recently issued research reports about the company. JPMorgan Chase & […]

Needham & Company LLC reissued their hold rating on shares of ZimVie (NASDAQ:ZIMV – Free Report) in a research report released on Thursday morning, Benzinga reports. Several other brokerages also recently commented on ZIMV. Barclays boosted their target price on ZimVie from $13.00 to $16.00 and gave the stock an underweight rating in a report […]

HC Wainwright reaffirmed their buy rating on shares of Innate Pharma (NASDAQ:IPHA – Free Report) in a research report sent to investors on Thursday morning, Benzinga reports. The firm currently has a $11.50 target price on the stock. Innate Pharma Price Performance Shares of Innate Pharma stock opened at $2.48 on Thursday. Innate Pharma has […]

StockNews.com assumed coverage on shares of Stratasys (NASDAQ:SSYS – Free Report) in a research report report published on Thursday. The brokerage issued a buy rating on the technology company’s stock. A number of other brokerages have also commented on SSYS. Needham & Company LLC reiterated a buy rating and issued a $16.00 price objective on […]

StockNews.com cut shares of Bel Fuse (NASDAQ:BELFB – Free Report) from a buy rating to a hold rating in a research report report published on Wednesday morning. A number of other equities research analysts have also issued reports on BELFB. Needham & Company LLC dropped their price objective on shares of Bel Fuse from $77.00 […]